AI can identify women at risk of breast cancer years in advance: Study
Artificial intelligence is able to identify women who have an elevated risk of developing breast cancer several years before ...
Phase III trial shows new treatment boosts cure rate for most common form of breast cancer
A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...
New Atlas14h
Breast cancer cure rates almost doubled in combo therapy trial
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
FiercePharma6h
Novartis' first Super Bowl ad aims to 'create a movement' with breast cancer awareness blitz
To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s ...
Rolling Out2h
Toxic beauty products raise breast cancer risk in women
Studies show beauty products targeting Black women contain dangerous chemicals linked to increased breast cancer risk and ...
Pharm Exec2h
FDA Approves AstraZeneca, Daiichi Sankyo’s Enhertu for Unresectable or Metastatic Hormone Receptor-Positive, HER2-Low Breast Cancer
Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...
Healio3h
FDA expands Enhertu approval for breast cancer
The FDA expanded the approval of trastuzumab deruxtecan for treatment of breast cancer.The new indication applies to use of ...
Rolling Out7h
Breakthrough brings hope for triple-negative breast cancer
Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks ...
Early detection is a game changer: Novartis makes bold play to prioritize breast health and inspire a new wave of breast cancer screenings
Novartis, a global leader in breast cancer care, today announced the launch of the "Your Attention, Please" campaign, which ...
FiercePharma5h
AZ, Daiichi’s Enhertu nabs 7th FDA nod, including in 'HER2-ultralow' use, in breast cancer first
Just 11 days after AstraZeneca and Daiichi Sankyo gained FDA approval | The FDA has cleared AstraZeneca and Daiichi Sankyo's ...
MP wants to dispel secondary breast cancer myths
An MP diagnosed with breast cancer for a second time wants to "debunk" misconceptions about metastatic cancers. Labour MP for ...
WebMD6d
FDA Approves New Treatment for Advanced Breast Cancer
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...